comparemela.com

Page 23 - Glenmark News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Glenmark launches fixed-dose combination diabetes drug in India

The combination contains Remogliflozin (100 mg) + Vildagliptin (50 mg) + Metformin (500/1000 mg) in a fixed-dose and must be taken twice daily to improve glycemic control in patients

Glenmark launches dry powder inhaler Tavulus in Spain

Drug makers Glenmark, Aurobindo recall multiple products in US

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.